Global RF Leader InMode is a leading global provider of innovative RF-based medical technologies with platforms designed to enable minimally invasive procedures across plastic surgery, gynecology, dermatology, ENT and ophthalmology. Availability varies by country, creating entry points for regulatory support and regional partnerships to accelerate local approvals and adoption. Target opportunities include clinics and hospital networks in geographies where products are approved, with region-specific demonstrations, locally trained clinicians, and multi-platform deployment packages.

Cross Specialty Growth Its platform strategy enables cross-selling across multiple specialties within the same clinics. Opportunities exist to offer bundled packages that cover complementary procedures, with integrated service plans, clinician training, and long-term device optimization to increase adoption and lifetime value.

Financial Strength Basis With a fortress balance sheet and robust cash flow, InMode is well positioned to support customer capital expenditures. The company has shown revenue growth and ongoing share repurchases, underscoring willingness to engage in financing options and multi-year procurement deals. Sales teams can propose leasing, financing, and comprehensive service contracts aligned with customers' budgeting cycles.

Leadership Momentum Recent leadership changes, including the appointment of Dr. Shlomo Nass as Chairman and Moshik Itzkovich as CFO, coupled with active investor conference participation, signal execution focus and governance enhancements. This momentum creates openings for strategic partnerships, co-development initiatives, and large-scale enterprise deals tied to new product launches and market expansion.

International Expansion International expansion is a core focus given the strong growth trajectory and multi-market opportunity beyond the US. BD efforts should prioritize markets with approved indications, establish regional distributors or reps, and tailor solutions to local regulatory and clinical needs, including training programs and certification to accelerate adoption across plastic surgery, gynecology, dermatology, ENT and ophthalmology.